Cat.#: ACPP-1264
| Despition | SorLA Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1101 | Recombinant Human SIRP alpha Protein (Fc Tag) (AC1101) | 50 µg | inquiry |
| ACPP-1747 | Human TSG Protein (AC1747) | 10 µg | inquiry |
| ACPP-1483 | Human ENO2 Protein (AC1483) | 5 µg | inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
| ACPP-1674 | Human KCNIP3 Protein (AC1674) | 5 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.